Minireviews
Copyright ©The Author(s) 2023.
World J Orthop. Jul 18, 2023; 14(7): 505-515
Published online Jul 18, 2023. doi: 10.5312/wjo.v14.i7.505
Table 2 Randomized controlled trials comparing platelet-rich plasma vs corticosteroid injections for rotator cuff tendinopathy
Ref.
Level of evidence
Design
Groups (n)
Dosis/quantity
Outcomes measure
Follow-up
Conclusions
Barreto et al[66], 2019ISubacromial PRP injections vs CI51 patients. PRP (26), CI (25)1/about 3 mLDASH, UCLA- SRS, CMS3mo, 6 moNo statistically significant differences
Dadgostar et al[63], 2021IUltrasound guided PRP injections vs CI58 patients. (30) PRP, (28) CI1/3 mL intra-articular, 3 mL intratendinoeusVAS, ROM, WORC, DASH, US supraspinatus thickness3 moPRP with similar results to CI
Kwong et al[70], 2021IUltrasound-guided leokocyte-poor PRP injection vs CI99 patients. PRP (47), CI (52)1/(3-5) mL intratendineous (non-specific) and the rest at the subacromial spaceVAS, ASES score, and WORC6, 12, 48 wkThe PRP group showed superior improvement in pain and function at short-term follow-up, without benefit at long-term follow-up
Ibrahim et al[68], 2019IUltrasound guided subacromial PRP vs CI30 patients. PRP (15), CI (15)1/2 mLVAS, SDQ, ROM Clnical tests, US findings8 wkBoth groups showed significant improvement. PRP is safe and can be used for PRCT
Jo et al[78], 2020IUltrasound guided allogenic PRP vs CI60 patients. PRP (30), CI (30)1/4 mLVAS, CMS, ASES, DASH, RC strength, ROM1, 4, 12, 24 wkPRP reduced pain and improved overall function at 6 mo. DASH score, overall function, and external rotation were significantly better in the PRP group
Pasin et al[79], 2019IPRP vs CI vs exercise60 patients. PRP (30), CI (30)1/4 mLVAS, quick DASH, UCLA SRS, SF-363, 8 wkPRP had better scores than CI and Physical Therapy even in a long time
Sabaah et al[80], 2020IProlotherapy vs CI and PRP40 patients. PRP (20), CI (20)2/5 mLVAS, WORC-Index, ROM and US findings12 wkProlotherapy was superior. PRP improve tendon healing
Sari et al[81], 2020IUltrasound guided PRP vs CI, prolotherapy and lidocaine60 patients. PRP (30), CI (30)1/5 mLVAS, ASES and WORC3, 12, 24 wkCI were better at 3 wk. NO difference at 12 wk. PRP had better outcomes at 24 mo
Thepsoparn et al[82], 2021IUltrasound guided leukocyte-poor PRP vs CI31 patients. PRP (15), CI (16)1/5 mLVAS and OSS4, 24 wkNo difference at 4 wk. PRP had better results at 24 wk for PRCT. No complications